Showing results (621-630 of 1,091) with videos related to

Sort By:
Pageof 110
Cancer|July 16, 2008
Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemiaApostolia-Maria Tsimberidou, Hagop M Kantarjian, Sijin Wen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 1, 2009
Utility of the World Heath Organization classification criteria for the diagnosis of systemic mastocytosis in bone marrowMalisha R Johnson, Srdan Verstovsek, Jeffrey L Jorgensen, et al.
British Journal of Haematology|February 2, 2021
Expression of the novel tumour suppressor sterile alpha motif and HD domain-containing protein 1 is an independent adverse prognostic factor in classical Hodgkin lymphomaIoanna Xagoraris, Theodoros P Vassilakopoulos, Elias Drakos, et al.
Journal of Hematology & Oncology|August 9, 2012
Detection of ABCC1 expression in classical Hodgkin lymphoma is associated with increased risk of treatment failure using standard chemotherapy protocolsWesley Greaves, Lianchun Xiao, Beatriz Sanchez-Espiridion, et al.
The Kaohsiung Journal of Medical Sciences|February 16, 2023
Distribution and clinical features of lymphomas involving skin in TaiwanCheng-Lin Wu, Su-Wei Chang, Julia Yu-Yun Lee, et al.
American Journal of Clinical Pathology|March 8, 2023
T-Cell Prolymphocytic Leukemia With t(X;14)(q28;q11.2): A Clinicopathologic Study of 15 CasesZhihong Hu, L Jeffrey Medeiros, Mina Xu, et al.
The American Journal of Surgical Pathology|October 9, 2015
High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor PrognosisShaoying Li, Vivian L Weiss, Xuan J Wang, et al.
Human Pathology|December 30, 2022
Classic Hodgkin lymphoma with marked granulomatous reaction: A clinicopathologic study of 20 casesJie Xu, Shaoying Li, C Cameron Yin, et al.
Leukemia Research|May 31, 2022
Differential characteristics of TP53 alterations in pure erythroid leukemia arising after exposure to cytotoxic therapyMehrnoosh Tashakori, Wei Wang, Tapan M Kadia, et al.
Pageof 110